Introduction: In this significant decision, the High Court at Calcutta, Intellectual Property Rights Division, has underscored the imperative of maintaining distinct procedural pathways for the examination of patent applications under Sections 14 and 15 of the Patents Act, 1970, and the adjudication of pre-grant oppositions under Section 25(1) of the same Act. The case of UPL Limited versus Haryana Pesticides Manufacturers Association & Anr. highlights the consequences of procedural consolidation where separate hearings and reasoned orders are mandated by the statutory framework. The judgment remands a rejected patent application for fresh consideration, emphasizing adherence to principles of natural justice and the independent character of examination and opposition proceedings. This ruling aligns with recent judicial trends that seek to prevent the conflation of these distinct stages while ensuring that the Controller of Patents exercises independent scrutiny untainted by mechanical adoption of third-party submissions.
Factual Background: The dispute centers on a patent application filed by UPL Limited on 26 March 2018, bearing number 201831011137, titled “Herbicidal Combinations.” The claimed invention pertains to synergistic herbicidal compositions combining active ingredients from three distinct classes: a triazolone herbicide, a Photosystem II inhibitor herbicide, and either an ALS inhibitor herbicide from the imidazolinone family or a bleacher herbicide. The applicant asserted that these combinations exhibited unexpected synergistic efficacy in controlling undesirable weeds, an advantage not achievable when the individual components were applied alone. The application was published on 27 September 2019. Following examination, the Patent Office issued a First Examination Report (FER) on 24 January 2020, raising objections primarily on grounds of lack of novelty and inventive step. In response, the applicant amended the claims by deleting the compound amicarbazone and submitted data purporting to demonstrate synergistic effects. Subsequently, the Haryana Pesticides Manufacturers Association filed a pre-grant opposition under Section 25(1) on 30 September 2020, contesting the application on multiple grounds including lack of novelty, obviousness, and the invention constituting a mere admixture falling within the prohibition under Section 3(e) of the Act. After a combined hearing on 7 April 2022 and written submissions, the Controller passed an order dated 27 April 2023 rejecting the application, relying inter alia on prior art documents introduced during the opposition.
Procedural Background: The procedural timeline reveals a sequence that ultimately became the focal point of challenge. After publication, the FER cited six prior art documents that mirrored those identified in the International Search Report. The applicant responded on 22 July 2020, expressly requesting a hearing under Section 14 should the Controller remain dissatisfied. No separate hearing was afforded at the examination stage. The pre-grant opposition introduced additional prior art documents (D3 to D5) beyond those common with the FER (D1 and D2). A single hearing addressed both the outstanding examination objections and the opposition grounds. The Controller thereafter issued a composite order rejecting the application without delineating which portions addressed examination objections under Section 15 and which disposed of the opposition under Section 25(1). Aggrieved, UPL Limited preferred an appeal under Section 117A of the Act, contending that the consolidation violated statutory mandates and principles of natural justice. The private opponent and the Controller defended the procedure, asserting that consolidation was permissible and that the order was adequately reasoned.
Reasoning and Decision of Court: The court examined the statutory architecture of the Patents Act and Rules, concluding that examination proceedings under Sections 14–15 and pre-grant opposition under Section 25(1) constitute distinct and independent stages. The court observed that Rule 55(5) permits simultaneous decision of the application and representation but does not authorize merger of hearings or obliteration of procedural separation. Where objections in the FER differ from those in the opposition, and particularly where new prior art emerges only in opposition, separate hearings are obligatory to afford the applicant a meaningful opportunity to address each set of concerns. The court found that the applicant had expressly sought a hearing in response to the FER, a request that went unheeded. Furthermore, the inability to locate one cited prior art document (D4) and the absence of any response from the Controller compounded the prejudice. The composite order was held vitiated by its failure to distinguish between examination and opposition findings, rendering it impossible to discern independent application of mind by the Controller. The court noted with concern the Controller’s near-verbatim reproduction of the opponent’s submissions, concluding that such mechanical adoption evidenced absence of reasoned scrutiny. Drawing upon precedents including Gilead Pharmasset LLC v. Union of India (2015 SCC OnLine Del 7014) and the recent Division Bench ruling in Novartis AG v. Natco Pharma Limited (2024 SCC OnLine Del 152), the court reaffirmed that pre-grant opposition serves an assistive rather than adversarial role, and opponents possess no locus to participate in pure examination proceedings. Consequently, the appeal was allowed, the impugned order set aside, and the application remanded to a different Controller for fresh consideration with directions to afford separate hearings and pass a speaking order within twelve weeks.
Point of Law Settled in the Case
The judgment crystallizes several critical propositions in Indian patent jurisprudence. First, examination under Sections 14–15 and pre-grant opposition under Section 25(1) are separate and independent proceedings that must ordinarily be heard and decided distinctly, particularly when objections or prior art differ between stages. Consolidation, while permissible in appropriate cases for simultaneous disposal, cannot extinguish the applicant’s statutory right to separate hearings where prejudice is demonstrated. Second, a composite order addressing both streams must clearly demarcate portions relating to examination and opposition respectively, failing which it stands vitiated. Third, the Controller is obliged to apply independent mind and furnish reasons, and mechanical adoption of an opponent’s submissions constitutes abdication of quasi-judicial function. Fourth, pre-grant opponents enjoy no right of audience or participation in the examination process, their role being confined to aiding the Controller through representation on specified grounds. Fifth, violation of these procedural safeguards amounts to breach of natural justice warranting remand, even mindful of the general reluctance to remit matters to expert tribunals. The decision thus reinforces the structural separation articulated in Novartis and allied rulings, ensuring that the expeditious yet rigorous framework envisaged by the legislature remains intact.
Case Title: UPL Limited Vs Haryana Pesticides Manufacturers Association & Anr.
Date of Order: 05.02.2026
Case Number: IPDPTA No.116 of 2023
Name of Court: High Court at Calcutta, Intellectual Property Rights Division
Name of Hon’ble Judge: Ravi Krishan Kapur, J.
Disclaimer: Readers are advised not to treat this as substitute for legal advise as it may contain errors in perception, interpretation, and presentation
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Suggested Titles for the Article
Calcutta High Court Emphasizes Procedural Separation in Patent Examination and Pre-Grant Opposition: Analysis of UPL Ltd. v. Haryana Pesticides Manufacturers Association
Remand for Procedural Infirmity: Calcutta High Court Reinforces Independent Examination and Opposition Stages under the Patents Act
Distinct Hearings and Reasoned Orders Mandatory: Key Takeaways from UPL Limited’s Successful Patent Appeal
Safeguarding Natural Justice in Patent Grants: The UPL Herbicide Combination Case
Suggested Tags
Patent Law, Pre-Grant Opposition, Section 25(1) Patents Act, Examination Proceedings, Section 14-15 Patents Act, Procedural Fairness, Natural Justice, Composite Orders, Synergistic Herbicide Combinations, Indian Patent Office, Calcutta High Court, Remand in Patent Appeals, Inventive Step, Section 3(e) Objection
Headnote
Patents Act, 1970 — Sections 14, 15, 25(1) and Rule 55(5) — Examination and pre-grant opposition — Distinct and independent proceedings — Requirement of separate hearings where objections or prior art differ — Composite order must demarcate examination and opposition findings — Mechanical adoption of opponent’s submissions vitiates order — Violation of natural justice warrants remand to different Controller for fresh consideration — Appeal allowed.
Held: Where FER objections and opposition grounds are not identical and new prior art is introduced in opposition, separate hearings under Sections 14 and 25(1) are mandatory. Controller must independently apply mind and provide reasons. Pre-grant opponent has no locus in examination proceedings. Matter remanded for de novo consideration with liberty to all parties on merits. (Paras 8–14)
Novartis AG v. Natco Pharma Limited (2024 SCC OnLine Del 152) and Gilead Pharmasset LLC v. Union of India (2015 SCC OnLine Del 7014) followed.
=====
The Calcutta High Court, in a significant ruling delivered by Justice Ravi Krishan Kapur, has set aside the rejection of a patent application for a herbicidal composition filed by UPL Limited. The court found serious procedural irregularities in the manner in which the Controller of Patents handled the pre-grant opposition and the examination process concurrently, without affording separate hearings as contemplated under the Patents Act, 1970. The matter has been remanded for fresh consideration by a different Controller, emphasizing the importance of adhering to statutory separation between examination proceedings and pre-grant opposition proceedings, along with strict compliance with principles of natural justice.
**Introduction**
This judgment addresses a critical aspect of Indian patent prosecution involving the interplay between the examination of patent applications under Sections 14 and 15 of the Patents Act, 1970, and pre-grant oppositions filed under Section 25(1). The court examined whether these distinct statutory stages can be merged into a single composite order without separate hearings, particularly when new prior art documents are introduced during opposition that were not part of the First Examination Report (FER). The decision reinforces the independent nature of these proceedings, the mandatory requirement of reasoned orders with independent application of mind, and the limited participatory role of pre-grant opponents in the examination stage. It draws heavily on precedents emphasizing procedural fairness in quasi-judicial patent decisions and highlights that procedural lapses vitiating natural justice warrant remand, even in technical matters.
**Factual Background**
UPL Limited filed Patent Application No. 201831011137 on March 26, 2018, claiming a herbicidal combination for controlling undesirable plants (weeds). The invention involved a synergistic composition comprising a Triazolone herbicide, a Photosystem II inhibitor herbicide, and either an ALS inhibitor (from Imidazolinone class) or a bleacher herbicide. The applicant asserted that the combination exhibited unexpected synergistic weed control, superior to individual components. The application was published on September 27, 2019. A First Examination Report was issued on January 24, 2020, raising objections including lack of novelty, inventive step, and sufficiency. In response, filed on July 22, 2020, the applicant amended Claim 1 by deleting the compound amicarbazone to overcome novelty objections and requested a hearing under Section 14. A pre-grant opposition was filed by Haryana Pesticides Manufacturers Association (respondent no.1) on September 30, 2020, under Section 25(1), alleging lack of novelty (Section 25(1)(b)), lack of inventive step (Section 25(1)(e)), and the invention being a mere admixture not qualifying as an invention under Section 3(e). The opposition introduced additional prior arts (D3 to D5) not cited in the FER. Hearings and written submissions followed, culminating in a composite impugned order dated April 27, 2023, rejecting the application.
**Procedural Background**
The applicant challenged the impugned order before the Calcutta High Court in IPDPTA No.116 of 2023. The primary grievance centered on procedural violations: no separate hearing was granted under Section 14 despite the explicit request in the FER reply; the Controller passed a single composite order disposing of both examination and opposition proceedings without delineating portions attributable to each; new prior arts introduced in opposition were considered without adequate opportunity to respond; the impugned order mechanically reproduced the opponent's submissions without independent reasoning or analysis of the applicant's data and arguments; and one cited prior art (D4) was untraceable and not provided despite requests. The Controller defended the consolidation as permissible, while the opponent supported the rejection on substantive grounds including lack of synergy proof and admixture nature.
**Reasoning and Decision of Court**
The court held that examination under Sections 14-15 and pre-grant opposition under Section 25(1) constitute distinct, independent stages under the statutory scheme. The opponent has no right of audience or participation in the examination proceeding, which remains confined between the applicant and the Controller. Reliance was placed on Novartis AG vs Natco Pharma Limited (2024 SCC OnLine Del 152), which clarified that opposition aids but does not supplant or merge with independent examination; the opponent's hearing right under Rule 55(5) is limited to the representation grounds. The court found a serious procedural infirmity in the composite order without separate hearings, especially since objections and prior arts differed between FER and opposition. This denied natural justice, as the applicant could not adequately address new citations. The impugned order lacked reasons, mechanically adopted opponent's views without dealing with applicant's submissions, data, or case laws, violating the principle that reasons form the soul of quasi-judicial orders (S.N. Mukherjee vs Union of India). The court distinguished cases cited by the opponent on sufficiency, noting such grounds were not the basis of rejection and the opponent lacked locus in appeal on waived FER objections. Finding violation of natural justice and procedural impropriety going to the root, the court remanded the matter to a different Controller for fresh consideration after adequate hearings and consideration of all materials, without expressing views on merits. The remand was directed within twelve weeks from communication of the order.
**Point of Law Settled in the Case**
The judgment settles that pre-grant opposition and patent application examination are statutorily separate proceedings that cannot be merged into a single composite order without separate hearings under Sections 14 and 25(1) respectively, particularly when new prior arts or distinct objections arise in opposition. The Controller must pass reasoned orders with independent application of mind, and failure to provide requested hearings under Section 14, or to delineate statutory stages in composite orders, constitutes violation of natural justice warranting setting aside and remand. Pre-grant opponents have no participatory right in examination proceedings, and their role is confined to aiding holistic assessment without overriding the Controller's independent duty.
**Case Detail**
- **Title**: UPL Limited Vs Haryana Pesticides Manufactures Association & Anr.
- **Date of Order**: 05.02.2026
- **Case Number**: IPDPTA No.116 of 2023
- **Neutral Citation**: (Not available in public domain records as of current date; may be assigned subsequently by the Calcutta High Court registry)
- **Name of Court**: High Court at Calcutta (Intellectual Property Rights Division, Original Side)
- **Name of Hon'ble Judge**: Justice Ravi Krishan Kapur
**Disclaimer**: Readers are advised not to treat this as substitute for legal advise as it may contain errors in perception, interpretation, and presentation
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
**Suggested Titles for the Article**
1. Calcutta High Court Remands UPL Herbicidal Patent Rejection: Mandates Separate Hearings for Examination and Pre-Grant Opposition
2. Procedural Fairness in Patent Prosecution: Calcutta HC Sets Aside Composite Rejection Order for Violating Natural Justice
3. Separation of Examination and Pre-Grant Opposition Proceedings: Landmark Clarification by Calcutta High Court in UPL Limited Case
4. Natural Justice Prevails: Calcutta HC Quashes Patent Refusal Due to Merged Proceedings and Lack of Reasons
**Suggested Tags**
Patent Law, Pre-Grant Opposition, Section 25(1) Patents Act, Section 14 & 15 Hearing, Natural Justice in Patent Proceedings, Composite Order Invalidity, Remand by Calcutta High Court, Herbicidal Composition Patent, UPL Limited Judgment, Procedural Irregularity in IPO, Inventive Step Rejection, Synergistic Herbicidal Combinations
**Headnote**
Calcutta High Court allows appeal against rejection of patent application for herbicidal combinations; sets aside impugned order for procedural infirmity in merging examination and pre-grant opposition without separate hearings, lack of reasoned independent application of mind, and violation of natural justice; matter remanded for fresh consideration by different Controller within 12 weeks, leaving merits open; reinforces statutory distinction between Sections 14-15 and 25(1) proceedings.
==========
UPL Limited's patent application for a herbicidal combination comprising Triazolone herbicide, Photosystem II inhibitor, and either ALS inhibitor (Imidazolinone) or bleacher herbicide was rejected by the Controller via a composite order dated 27 April 2023 on grounds of lack of novelty, lack of inventive step, and being a mere admixture under Section 3(e) following a pre-grant opposition by Haryana Pesticides Manufacturers Association.
The applicant challenged the order before the Calcutta High Court alleging procedural violations including no separate hearing under Section 14 despite request, merger of examination and opposition proceedings into one order without delineation, consideration of new prior arts (D3–D5) introduced only in opposition without adequate opportunity, mechanical adoption of opponent's submissions without independent reasoning or analysis of applicant's data, and lack of reasons.
The Court found serious procedural infirmity and violation of natural justice, set aside the impugned order, and remanded the matter to a different Controller for fresh consideration after affording proper hearings and full consideration of materials, without expressing any view on merits, directing completion within twelve weeks.
Law Point Settled:
Examination proceedings under Sections 14–15 and pre-grant opposition under Section 25(1) are distinct, independent stages that cannot be merged into a single composite order without separate hearings, particularly when new prior arts or different objections arise in opposition (Para 8–10, 14).
The pre-grant opponent has no right of audience or participation in the examination proceeding, which remains confined between the applicant and the Controller; the opponent's hearing right under Rule 55(5) is limited to the opposition representation (Para 8, 12).
- Passing a composite order without delineating portions attributable to Section 14/15 and Section 25(1), and without granting a requested hearing under Section 14, constitutes serious procedural irregularity and violation of natural justice warranting setting aside of the order (Para 10, 14, relying on Gilead Pharmasset LLC v Union of India, 2015 SCC OnLine Del 7014).
Case Title: UPL Limited Vs Haryana Pesticides Manufactures Association:05.02.2026:IPDPTA No. 116 of 2023:CalHC: Hon’ble Justice Ravi Krishan Kapur
Disclaimer: Readers are advised not to treat this as substitute for legal advise as it may contain errors in perception, interpretation, and presentation
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
#IPUpdate #IPCaselaw #IPCaseLaw #IPLaw #IPRNews #IPIndiaupdate #Trademark #Copyright #DesignLaw #PatentLaw #Law #Legal #IndianIPUpdate #AdvocateAjayAmitabhSuman #IPAdjutor